Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
Poziotinib is an orally active, irreversible, pan-HER tyrosine kinase inhibitor used to treat non-small cell lung cancer, breast cancer, and gastric cancer. Poziotinib is currently under clinical investigation, and understanding its drug-drug interactions is extremely important for its future develo...
Saved in:
Main Authors: | Jinhui Wang (Author), Feifei Chen (Author), Hui Jiang (Author), Jia Xu (Author), Deru Meng (Author), Peiwu Geng (Author), Dapeng Dai (Author), Jingbo Hu (Author), Yunfang Zhou (Author), Quan Zhou (Author), Shuanghu Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
by: Weiping Ji, et al.
Published: (2021) -
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
by: Yiran Wang, et al.
Published: (2020) -
Screening of the whole human cytochrome P450 complement (CYPome) with enzyme bag cocktails
by: Sangeeta Shrestha Sharma, et al.
Published: (2020) -
An in-vitro cocktail assay for assessing compound-mediated inhibition of six major cytochrome P450 enzymes
by: Jing-Jing Wang, et al.
Published: (2014) -
Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo
by: Yunfang Zhou, et al.
Published: (2020)